Kunle O. Odunsi

Kunle O. Odunsi

Obstetrics and Gynecology
5758 S. Maryland Ave.
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 264 publications

Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120.

Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120.

Journal: Cancers
Published: June 09, 2026

Integrative Computational Approaches to Prostate Cancer with Conditional Reprogramming and AI-Driven Precision Medicine.

Integrative Computational Approaches to Prostate Cancer with Conditional Reprogramming and AI-Driven Precision Medicine.

Journal: Cells
Published: March 19, 2026

Rethinking ovarian cancer III: the past decade and future directions.

Rethinking ovarian cancer III: the past decade and future directions.

Journal: Nature reviews. Cancer
Published: February 23, 2026

Adoptive cell therapy for ovarian cancer.

Adoptive cell therapy for ovarian cancer.

Journal: Clinical advances in hematology & oncology : H&O
Published: February 20, 2026

Tracking the Metabolites of Health and Disease Using Artificial Intelligence.

Tracking the Metabolites of Health and Disease Using Artificial Intelligence.

Journal: Diseases (Basel, Switzerland)
Published: November 28, 2025

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Journal: ImmunoHorizons
Published: November 06, 2025

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications
Published: September 09, 2025

Probing Cellular Activity Via Charge-Sensitive Quantum Nanoprobes.

Probing Cellular Activity Via Charge-Sensitive Quantum Nanoprobes.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 15, 2025

mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors.

mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors.

Journal: Journal for immunotherapy of cancer
Published: March 06, 2025

Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy.

Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy.

Journal: Cell reports. Medicine
Published: December 02, 2024

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Journal: Research square
Published: October 07, 2024

Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.

Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.

Journal: European journal of human genetics : EJHG
Published: October 04, 2024
Showing 1-12 of 264

Last Updated: 09/26/2026